Premium
Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose
Author(s) -
Goodnough Lawrence Tim,
Kuter David,
McCullough Jeffrey,
Brecher Mark E.
Publication year - 1998
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/(sici)1098-1101(1998)13:3<114::aid-jca4>3.0.co;2-6
Subject(s) - apheresis , medicine , platelet , plateletpheresis , platelet transfusion
Emerging issues in stimulating apheresis platelet donors with platelet growth factors, the relative costs of apheresis and random donor platelet concentrates, optimal platelet transfusion dose, and leucoreduction of platelet products have caused renewed debate regarding apheresis products vs. random, pooled concentrates. The future role of apheresis products in platelet transfusion therapy will in large part be determined by costs, which are increasingly recognized to be influenced by donor platelet count, apheresis yield, and platelet transfusion dose. J. Clin. Apheresis 13:114–119, 1998. © 1998 Wiley‐Liss, Inc.